Back

Association of Life's Essential 8 and psoriasis-atherosclerotic cardiovascular disease (PSO-ASCVD) comorbidity: a prospective cohort study

31 August 2026 (14:30 - 14:42)
Organised by: Logo
Congress Presentation Part of: Metabolic risk scores and atherosclerotic cardiovascular disease Scores ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Fangshun Tan

Beijing (China)

4 More presentations in this session

Presentation thumbnail
Combined elevation of lipoprotein(a) and polygenic risk in index patients identifies family members at high risk of coronary artery disease
Mr M. Annink (Amsterdam, NL)
Abstract
Presentation thumbnail
Association between lipoprotein(a) and ischemic brain lesions in patients with atrial fibrillation: insight from the Swiss-AF cohort
Doctor N. Johner (Bordeaux, FR)
Abstract
Presentation thumbnail
The metabolic score for insulin resistance (METS-IR) predicts MACE and is correlated to plasma levels of leptin and sRAGE: validation and mechanistic insights from a Swedish population-based cohort
Doctor F. Hammareus (Linkoping, SE)
Abstract
Presentation thumbnail
Proteomic signatures reveal why not all apolipoprotein B-containing lipoproteins are equal in atherosclerosis
Doctor J. Morze (Gothenburg, SE)
Abstract

Access the full session

Session thumbnail
Metabolic risk scores and atherosclerotic cardiovascular disease

The Event

Event poster

ESC Congress 2026

31 August 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Association between Life's Essential 8 scores with 5-year all-cause and cardiovascular mortality among postmenopausal females: based on a cohort study
29 August 2025
thumbnail
Congress Presentation
Psoriatic arthritis: changes in size, shape and function of the heart
29 June 2021
thumbnail
Congress Presentation
The association between visit-to-visit variability in established risk factors and incident CVD: a post-hoc analysis of the multi-ethnic study of atherosclerosis
5 April 2025
thumbnail
Congress Presentation
Prevalence, determinants, and time trends of LS7 Cardiovascular Health in the WHO African Region 2003 to 2022
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources